Abstract

Article Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients Graphical Abstract Highlights d Consensus COVID-19 immune signature between solid cancer and non-cancer patients d Resolution of immune dysregulation and sustained seroconversion in solid cancers d Delayed or absent humoral responses observed in hematological cancer patients d Prolonged viral clearance and post-virus immune legacy in hematological cancers

